Haryana, India

Jigar Bhavsar

This inventor holds 1 USPTO granted patent. Top assignee: Mankind Pharma Ltd.. Active years: 2019.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jigar Bhavsar: Innovator in Pharmaceutical Chemistry

Introduction

Jigar Bhavsar is a notable inventor based in Haryana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work focuses on improving the efficacy of medications through innovative chemical formulations.

Latest Patents

Jigar Bhavsar holds a patent for "Fluoroquinolone carboxylic acid compounds and use thereof for the preparation of besifloxacin hydrochloride." This invention relates to novel fluoroquinolone carboxylic acid compounds and derivatives of Formula-I, and their salts wherein R represents H or halogen. The patent also details the use of these compounds for the preparation of Besifloxacin hydrochloride, a medication used to treat bacterial infections.

Career Highlights

Jigar Bhavsar is currently employed at Mankind Pharma Ltd., a prominent pharmaceutical company in India. His role involves research and development, where he applies his expertise in chemistry to create effective pharmaceutical solutions. His innovative approach has led to the successful development of new compounds that enhance drug formulations.

Collaborations

Jigar has collaborated with several professionals in his field, including Bhuwan Bhashkar and Anil Kumar. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical research.

Conclusion

Jigar Bhavsar's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His patent for fluoroquinolone carboxylic acid compounds showcases his commitment to improving healthcare through scientific research. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…